Origin Agritech Limited develops agricultural technology and crop seed biotechnology in China, with news centered on corn seed R&D, genetic improvement, commercialization programs, and regulatory authorizations for crop seed production and GMO-related operations. Company updates frequently cover new corn varieties such as Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, as well as distributor initiatives including the Golden Harvest Club.
Recurring developments also include biotechnology pipeline work involving glyphosate tolerance, Bt pest-resistance traits, phytase corn, gene editing technology, research collaborations, market expansion in Chinese agricultural regions, annual results, financing actions, and board or finance leadership changes.
Origin Agritech (NASDAQ: SEED) announced a significant breakthrough in maize gene editing, published in the journal Nature. The study demonstrates the successful use of maize induction line gene editing technology to improve leaf angle in maize inbred lines, potentially enhancing yield at high planting densities. Origin, with China Agricultural University, created the world's first efficient genetic transformation system for maize induction line Hi3, significantly reducing the time required compared to traditional methods. The commercialization of this technology in China is expected within 1-2 years, with a market potential exceeding $1.5 billion. This advancement could revolutionize maize cultivation, improve crop performance, and support sustainable farming.
Origin Agritech (NASDAQ: SEED) reported strong financial results for the first half of FY2024, ending March 31, 2024. The company saw a 39.1% increase in net revenues, reaching RMB 92 million (US$13 million), and decreased operating expenses by 10% to RMB 13.4 million (US$1.9 million). This led to a net profit of RMB 1.4 million (US$0.2 million), compared to a net loss of RMB 1.1 million in the same period last year. Earnings per share were RMB 0.21 (US$0.03).
Operationally, Origin Agritech received a GMO safety certificate for its transgenic maize, BBL2-2. Additionally, two new hybrids are expected to receive regulatory approval by summer 2024, with commercial availability in 2025. The company also announced a breakthrough in high-yield corn, showing a 50% yield increase. Origin Agritech remains focused on securing regulatory approvals and preparing for the commercial launch of new products.
Origin Agritech (NASDAQ: SEED) has received a GMO safety certificate for its transgenic maize, BBL2-2, containing two insect-resistant genes and one herbicide-tolerance gene. The certification marks a significant milestone for the company and the agricultural sector, allowing for the commercial rollout of BBL2-2. This new product is expected to enhance agricultural productivity, sustainability, and pest management, setting a new standard in sustainable agriculture.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.